Literature DB >> 15518032

Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon.

Zaher K Otrock1, Gerard O Oghlakian, Mariana M Salamoun, Maurice Haddad, Abdul Rahman N Bizri.   

Abstract

OBJECTIVE: To determine the incidence of urinary tract infections (UTIs) following transrectal ultrasound guided needle biopsy of the prostate (TRUBP) and the bacteriology of these infections.
DESIGN: Retrospective evaluation of the charts and records of all patients who underwent TRUBP between June 1, 2002, and August 31, 2003.
SETTING: American University of Beirut Medical Center, a tertiary-care center in Lebanon. PATIENTS: Two hundred seven patients underwent TRUBP. All received prophylactic antibiotics. One hundred twenty (58%) received ciprofloxacin alone, whereas 87 (42%) received both ciprofloxacin and gentamicin. Sixty-one patients (29.5%) had an enema prior to the procedure, whereas 146 (70.5%) did not.
RESULTS: Thirteen patients (6.3%) were admitted with UTI. All had rigors and fever on admission. Symptoms appeared at a mean of 2.7 days and the mean hospital stay was 9.2 days. The mean duration of antibiotic treatment was 23.2 days. Ten (77%) of the patients had positive bacteriology. Urine cultures were positive in 8 (61.5%) of the patients and blood cultures in 6 (46.2%). All positive cultures grew Escherichia coli resistant to ciprofloxacin, with 5 isolates producing extended-spectrum betalactamases.
CONCLUSIONS: TRUBP continues to be associated with significant infectious complications, especially UTI. Given the increasing incidence of antibiotic resistance mainly among the Enterobacteriaceae, antimicrobial prophylaxis practices should be reevaluated and the universal administration of quinolones alone or in combination with aminoglycosides should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518032     DOI: 10.1086/502312

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  13 in total

1.  Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate.

Authors:  Justin R Gyorfi; Christopher Otteni; Kevin Brown; Amar Patel; Kathleen Lehman; Brett E Phillips; Kalyan Dewan; Girish Kirimanjeswara; Jay D Raman
Journal:  World J Urol       Date:  2014-03-30       Impact factor: 4.226

2.  Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.

Authors:  Sinan Ekici; Melahat Cengiz; Güven Turan; Esra Ergün Alış
Journal:  Int Urol Nephrol       Date:  2011-05-06       Impact factor: 2.370

3.  Febrile infection in post-prostate biopsy: results of a ten-year single-institution study in South Taiwan.

Authors:  Yuh-Shyan Tsai; Chia-Hong Chen; Yeong-Chin Jou; Wen-Horng Yang; Chien-Chen Chang; Tzong-Shin Tzai
Journal:  Surg Infect (Larchmt)       Date:  2013-11-27       Impact factor: 2.150

Review 4.  Optimization of prostate biopsy: review of technique and complications.

Authors:  Marc A Bjurlin; James S Wysock; Samir S Taneja
Journal:  Urol Clin North Am       Date:  2014-05       Impact factor: 2.241

5.  Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?

Authors:  Jasmin Loh; Katie Baker; Swetha Sridharan; Peter Greer; Chris Wratten; Anne Capp; Sarah Gallagher; Jarad Martin
Journal:  Radiat Oncol       Date:  2015-02-13       Impact factor: 3.481

6.  Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: an eight-year single center experience.

Authors:  Bing-Juin Chiang; Yeong Shiau Pu; Shiu-Dong Chung; Shih-Ping Liu; Hong-Jeng Yu; Shuo-Meng Wang; Hong-Chiang Chang; I-Ni Chiang; Chao-Yuan Huang
Journal:  ScientificWorldJournal       Date:  2013-12-23

7.  Morbidity and psychological impact of prostate biopsy: the future calls for a change.

Authors:  Andrea Minervini; Gianni Vittori; Giampaolo Siena; Marco Carini
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

8.  A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during the perioperative period of ultrasound-guided transrectal prostate biopsy.

Authors:  L-D Qiao; S Chen; X-F Wang; W-M Yang; Y-J Niu; C-Z Kong; W Tang; X-F Gao; B-K Shi; Y-Q Na; X-D Zhang; J-Y Wang; Y Zhang; Z Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-16       Impact factor: 3.267

9.  Fluoroquinolone-Resistant Escherichia coli Infections After Transrectal Biopsy of the Prostate in the Veterans Affairs Healthcare System.

Authors:  Elie A Saade; Nuntra Suwantarat; Trina F Zabarsky; Brigid Wilson; Curtis J Donskey
Journal:  Pathog Immun       Date:  2016

10.  Microbiological characteristics of acute prostatitis after transrectal prostate biopsy.

Authors:  Jun-Ho Bang; Hyun-Sop Choe; Dong-Sup Lee; Seung-Ju Lee; Yong-Hyun Cho
Journal:  Korean J Urol       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.